☰

Jane L. Meza, Ph.D. - Publications

Affiliations: 
2000 The University of Nebraska - Lincoln, Lincoln, NE 
Area:
Statistics
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Ermoian RP, Breneman J, Walterhouse DO, Chi YY, Meza J, Anderson J, Hawkins DS, Hayes-Jordan AA, Parham DM, Yock TI, Donaldson SS, Wolden SL. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatric Blood & Cancer. PMID 28548706 DOI: 10.1002/Pbc.26540  0.398
2017 Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan A, Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. PMID 28211936 DOI: 10.1002/Cncr.30613  0.313
2014 Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan AA, Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3547-52. PMID 25267746 DOI: 10.1200/Jco.2014.55.6787  0.378
2011 Walterhouse D, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan AA, Parham D, Cripe TP, Meyer WH, Hawkins DS. Shorter duration therapy that includes vincristine (V), dactinomycin (A), and lower doses of cyclophosphamide (C) with or without radiation therapy for patients with newly diagnosed low-risk embryonal rhabdomyosarcoma (ERMS): A report from the Children's Oncology Group (COG). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9516. PMID 28019809 DOI: 10.1200/jco.2011.29.15_suppl.9516  0.303
2011 Raney RB, Walterhouse DO, Meza JL, Andrassy RJ, Breneman JC, Crist WM, Maurer HM, Meyer WH, Parham DM, Anderson JR. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1312-8. PMID 21357783 DOI: 10.1200/Jco.2010.30.4469  0.382
2011 Walterhouse DO, Meza JL, Breneman JC, Donaldson SS, Hayes-Jordan A, Pappo AS, Arndt C, Raney RB, Meyer WH, Hawkins DS. Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group. Pediatric Blood & Cancer. 57: 76-83. PMID 21298768 DOI: 10.1002/Pbc.22928  0.359
2004 Wharam MD, Meza J, Anderson J, Breneman JC, Donaldson SS, Fitzgerald TJ, Michalski J, Teot LA, Wiener ES, Meyer WH. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1902-8. PMID 15143083 DOI: 10.1200/Jco.2004.08.124  0.311
2001 Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease Journal of Clinical Oncology. 19: 3091-3102. PMID 11408506 DOI: 10.1200/Jco.2001.19.12.3091  0.345
2000 Donaldson SS, Meza JL, Breneman J, Crist W, Laurie F, Qualman S, Wharam M. Results from the IRS IV randomized trial of hyperfractionated radiation in children with rhabdomyosarcoma International Journal of Radiation Oncology Biology Physics. 48: 178. DOI: 10.1016/S0360-3016(00)80149-2  0.306
Show low-probability matches.